The value of postoperative hepatic arterial infusion following curative liver resection

Anticancer Research

Volumn 17, Issue 5 B, 1997, Pages 3825-3833

  Lorenz, M ^a   Staib Sebler, E ^a   Koch, B ^a   Gog, C ^a   Waldeyer, M ^a   Encke, A ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Adjuvant chemotherapy; Colorectal cancer; Hepatic arterial infusion; Liver resection

Indexed keywords

ANTINEOPLASTIC AGENT; FLOXURIDINE; FLUOROURACIL;

ADULT; AGED; ARTERY CATHETER; ARTICLE; BILIARY TRACT DISEASE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; DRUG INFUSION; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; LIVER RESECTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN TOXICITY; STOMATITIS; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIDOTES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FLOXURIDINE; FLUOROURACIL; HEPATECTOMY; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0031467486     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Parkin DM, Läära E, Muir CS: Estimates of the worldwide frequency of sixteen major cancer in 1980. Int JCancer 40: 184-194, 1988.
2. Berge T, Ekelund G, Mellner C, Phil B, Wenckert A: Carcinoma of the colon and rectum in a defined population - an epidemiological, clinical and post mortem investigation of colorectal carcinoma and coexisting benign polyps in Malmö, Sweden. Acta Chir Scand (suppl) 438: 1-86, 1973.
3. Eder M: Die Metastasierung - Fakten und Probleme aus human-pathologischer Sicht. Verh Dtsch Ges Path 68: 1-11, 1984.
4. Willet CG, Tepper JE, Cohen AM, Orlow E, Welch CE: Failure patterns following curative resection of colonic carcinoma. Ann Surg 200: 685 690, 1984.
5. Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE: Natural history of patients with untreated liver metastases from colorectal Cancer. Am J Surg 141: 586-589, 1981.
6. Bengmark S, Hafstrom L, Jeppsson B, Jonsson P, Ryden S, Sundquist K: Metastatic disease in the liver from colorectal cancer - an appraisal of liver surgery. World J Surg 6: 61-65, 1982.
7. Cady B, Monson DO, Swinton NW: Survival of patients after colonic resection for carcinoma with simultaneous liver metastases. Surg Gynecol Obstet 131: 697-700, 1970.
8. Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J et al: Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73: 727-731, 1986.
9. Fortner JG, Silva JS, Golbey RB, Cox EB, MacLean BJ: Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I Treatment by hepatic resection. Ann Surg 199: 306-316, 1984.
10. Hohenberger P, Schlag P, Schwarz V, Herfarth C: Tumour recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol 44: 245-251, 1990.
11. Adson MA, van Heerden JA, Adson MH, Wagner JS, Ilstrup DM: Resection of hepatic metastases from colorectal cancer. Arch Surg 119: 647-651, 1984.
12. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP: Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110: 13-24, 1991.
13. Cohen AM, Minsky BD, Schilsky RL: Colon Cancer in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology (ed 4). Philadelphia, Lippincott, pp 929-977, 1993.
14. National Institute of Health-Consensus-Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264: 1444-1146, 1990.
15. Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA, Goodmann PJ et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl JMed 322: 352-358, 1990.
16. August DA, Sugarbaker PH, Ottow RT, Gianola FJ, Philip PAC, Schneider PD: Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on Survival. Ann Surg 201: 210-218, 1985.
17. Curley SA, Roh MS, Chase JL, Hohn DC: Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg 166: 743-748, 1993.
18. Elias D, Lasser P, Rougier P, Nitenberg G, Theodore C, Lumbroso J: Early adjuvant intraportal chemotherapy after curative hepatectomy for colorectal liver metastases - a pilot study. Eur J Surg Oncol 13: 247-250, 1987.
19. Hodgson WJB, Friedland M, Ahmed T, Mittelman A, Berman H, Katz S et al: Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease. Ann Surg 203: 420-425, 1986.
20. Hughes K, Foster J: The role of adjuvant chemotherapy following curative hepatic resection of colorectal metastases. Proc Am Soc Clin Oncol 10: Abstr. 145, 1991.
21. Moriya Y, Sugihara K, Hojo K, Makuuchi M: Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: A pilot study. European J Surg Oncol 17: 519-525, 1991.
22. Klotz HP, Weder W, Largiader F: Local and systemic toxicity of intrahepatic-arterial 5-FU and high-dose or low-dose leucovorin for liver metastases of colorectal cancer. Surg Oncol 3: 11-16, 1994.
23. Morrow CE, Grage TB, Sutherland DER, Najarian JS: Hepatic resection for secondary neoplasms. Surgery 92: 610-610, 1982.
24. O'Connel MJ, Adson MA, Schutt AJ, Rubin J, Moertel CG, Ilstrup DM: Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc 60: 517-520, 1985.
25. Patt YZ, McBride CM, Ames FC, Claghorn LJ, Cleary KB, Boddie AW et al: Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer 59: 867-873, 1987.
26. Wagman JS, Kemeny MM, Leong L, Terz JJ, Hill LR, Beatty JD et al: A prospective randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 8: 1885-1893, 1990.
27. Schlag P, Manasterski M, Gerneth T, Hohenberger P, Dueck M, Herfarth C et al: Active specific immunotherapy with NDV modified autologous tumour cells following liver metastases resection in colorectal cancer. Cancer Immunother 35: 325-330, 1992.
28. Balch CM, Urist MM, Soong SJ, McGregor M: A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 198: 567-573, 1983.
29. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 107: 459-465, 1987.
30. Curley SA, Chase JI, Roh MS, Hohn DC: Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery 114: 928-935, 1993.
31. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statist Ass: 457-462, 1958.
32. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner IG et al: Resection of the liver for colorectal carcinoma metastases: A multiinstitutional study of patterns of recurrence. 833 Surgery 100: 278-284, 1986.
33. Finlay IG, McArdle CS: Occult hepatic metastases in colorectal carcinoma. Br J Surg 73: 732-735, 1986.
34. Panis Y, Riheiro J, Chretien Y, Nordlinger B: Dormant liver metastases: an experimental study. Br JSurg 79: 221-223, 1992.
35. Naniemo T, Takeichi N, Hata Y: Analysis of mechanism of the effect of partial hepatectomy on enhanced growth of liver cancer in rats: experimental analysis of the mechanism of recurrences after liver surgery in human liver cancer. Acta Hepatol Jpn 30: 889-897, 1989.
36. Fischer B, Fischer E: Experimental studies influencing hepatic metastases. Effect of partial hepatectomy. Cancer 12: 929-932, 1959.
37. Erlichman C, Marsoni S, Seitz JF, Skillings J, Shepherd L, Zee B et al: Event free and overall survival is increased by FUFA in resected B and C colon cancer: A prospective pooled analysis of 3 randomized trials (RCTS). Proc Am Soc Clin Oncol 13: Abstr. 562, 1994.
38. Douglass HO Jr: Adjuvant Treatment in Colorectal Cancer. An Update. World J Surg 11: 478-492, 1987.
39. Ackerman NB, Lien WM, Kondi ES, Silvermann NA: The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumours. Surgery 66: 1067-1072, 1969.
40. Cunliffe WJ, Sugarbaker PH: Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 76: 1082-1090, 1989.
41. Speyer JL, Collins JM, Dedrick RL: Phase I and pharmacological studies of Sfluorouracil administered intraperitoneally. Cancer Res 40: 567-572, 1980.
42. Herrmann G, Lorenz M, Kirkowa-Reimann M, Hottenrott C, Hubner K: Morphological changes after intra-arterial chemotherapy of the liver. Hepatogastroenterol 34: 5-9, 1987.
43. Hohn D, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ: Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 57: 465-470, 1986.
44. Lokich JJ: Optimal schedule tor 5-fluorouracil chemotherapy. Am J Clin Oncol 8: 445-448, 1985.
45. Hansen RM, Quebbeman E, Anderson T: 5-Fluorouracil by protracted venous infusion: a review of current progress. Oncology 46: 245-250, 1989.
46. O'Connell MJ, Martenson JA, Wieand HS, Krook JE, MacDonald JS, Haller DG: Improving adjuvant therapy for rectal cancer by combining protracted infusion Fluorouracil with radiation therapy after curative surgery. N Engl J Med 331: 502-507, 1994.
47. Riethmuller G, Schneider-Gadicke E, Schlimok G: Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 343: 1177-1183, 1994.